QuidelOrtho Corporation (QDEL) Dividend History

QuidelOrtho Corporation (QDEL) is a global leader in the development and manufacturing of diagnostic healthcare products. The company specializes in rapid diagnostic testing solutions, including point-of-care tests for infectious diseases, cardiac health, and respiratory illnesses. Formed from the merger of Quidel Corporation and Ortho Clinical Diagnostics, QuidelOrtho offers a broad portfolio of products used in hospitals, laboratories, and clinics to facilitate timely and accurate disease detection and management.

9975 Summers Ridge Road, San Diego, CA, 92121
Phone: (858) 552-1100
Website: https://www.quidelortho.com

Dividend History

QuidelOrtho Corporation currently does not pay dividends

Company News

Clinical Laboratory Molecular Diagnostics for Infectious Disease Market Research 2025-2029: Biotechnology and Genomics Drive Advancements, Impact of Multiplex Assays in Diagnosis and Treatment

The global molecular diagnostics for infectious disease market is poised for growth, driven by advancements in biotechnology and genomics, as well as the impact of multiplex assays on diagnosis and treatment. The report covers dynamic trends, including pathogen evolution, globalization, and climate change impacts, and provides insights on the U.S. Medicare Fee Schedules and global data.

GlobeNewswire Inc.

Featured Companies: A ABT BDX BIO BIO.B DHR HOLX QGEN TMO
Why QuidelOrtho Stock Bounced More Than 4% Higher Today

QuidelOrtho, a healthcare diagnostics company, is recovering well from the loss of its COVID-19-related business. The company's Q4 and full-year results beat analyst estimates, and its guidance for 2024 suggests continued recovery.

The Motley Fool
Infectious Disease Diagnostics Market to Reach USD 43.09 Billion by 2031 | SkyQuest Technology

The global infectious disease diagnostics market is projected to reach $43.09 billion by 2031, growing at a CAGR of 8.20% during the forecast period. The market is driven by advancements in diagnostic technologies, rising cases of infectious diseases, and increased R&D funding.

Benzinga

Featured Companies: ABT BDX BIO BIO.B CODX DHR OSUR QGEN RVTY TMO
Carlyle group entities sell over $4.8 million in QuidelOrtho stock - Investing.com

Entities associated with the Carlyle Group have sold over $4.8 million worth of shares in QuidelOrtho Corp, a company specializing in diagnostic substances. The sales were conducted in accordance with a Rule 10b5-1 trading plan, and the entities still hold a significant number of shares in the company.

Investing.com

Featured Companies: CG
Why Is QuidelOrtho (QDEL) Down 2.4% Since Last Earnings Report?

QuidelOrtho (QDEL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Investment Research

Featured Companies: SYK

Page data last updated 07/23/2025 10:02:47 UTC